Tecumseh Study of Illness. XIII. Influenza Infection and Disease, 1976-1981
Overview
Authors
Affiliations
The occurrence of influenza was followed in Tecumseh, Michigan during the five year period 1976-1981 by identifying onset of acute respiratory illness and by virus isolation and serology. Type B outbreaks were observed in 1976-1977 and 1979-1980, type A (H3N2) in 1977-1978 and 1980-1981, and type A (H1N1) viruses in 1977-1978, 1978-1979, and 1980-1981. Evidence of low level circulation of viruses in the year preceding an outbreak was not obtained. Age-specific isolation rates from specimens collected by the community physicians differed from age-specific isolation rates from specimens collected from the surveillance, suggesting the operation of a selection mechanism in the former. Symptoms associated with virus isolation were strongly influenced by age. Within age groups, several variables, especially median duration, indicated type A (H3N2) had produced the most severe illnesses, type A (H1N1) the mildest, with type B intermediate. Age-specific infection rates determined by serology for the 1976-1977 and 1977-1978 influenza seasons confirmed the consistently high rates for type A (H3N2) in children with some fall-off with increasing age. Type A (H1N1) rates peaked in children aged 5-19 years and type B in children aged 5-14 years. This may be related in part to insensitivity of the hemagglutination inhibition test in those under age 5 years. Infection with type A (H1N1) was detected at low frequency in adults. Pathogenicity was calculated based on the serologic data. It was estimated for all ages combined that, at a minimum, type A (H3N2) infection produced febrile illness in 25% of cases and type B infection produced respiratory illness in 34% of cases.
Artificial intelligence for modelling infectious disease epidemics.
Kraemer M, Tsui J, Chang S, Lytras S, Khurana M, Vanderslott S Nature. 2025; 638(8051):623-635.
PMID: 39972226 DOI: 10.1038/s41586-024-08564-w.
Targets of influenza human T-cell response are mostly conserved in H5N1.
Sidney J, Kim A, de Vries R, Peters B, Meade P, Krammer F mBio. 2024; 16(2):e0347924.
PMID: 39714185 PMC: 11796400. DOI: 10.1128/mbio.03479-24.
Cohen C, du Plessis M, Martinson N, Moyes J, Walaza S, Wolter N J Infect Dis. 2024; 231(2):e328-e336.
PMID: 39542652 PMC: 11841623. DOI: 10.1093/infdis/jiae550.
Zhang L, Li Y, Ma N, Zhao Y, Zhao Y Sci Rep. 2024; 14(1):3079.
PMID: 38321190 PMC: 10847441. DOI: 10.1038/s41598-024-53767-w.
Goldstein E Epidemiol Infect. 2023; 151:e148.
PMID: 37622317 PMC: 10540177. DOI: 10.1017/S0950268823001358.